Use of Intrathecal Fentanyl and Development of Hyperalgesia in Patients Undergoing Elective Cesarean
NCT ID: NCT02387060
Last Updated: 2015-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
80 participants
INTERVENTIONAL
2014-08-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Opioid induced hyperalgesia could be an explanation studies in animal models. Through mechanisms where N-methyl-D-aspartate receptors, glutamatergic system disturbances and changes in intracellular calcium regulation involved.
The hyperalgesia induced by intrathecal opioids is controversial. The investigators propose a model study in patients undergoing cesarean section to study the secondary hyperalgesia induced based on the study of nociceptive thresholds with two methods opioids: Von Frey filaments and digital algometer.
If intrathecal fentanyl is used in spinal anesthesia for elective cesarean section, then, an increase in sensitivity will occur. This increase can be measured by von Frey filaments, expressed in increased requirement clinically opioids.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intrathecal Naloxone in the Incidence of Pruritis After C.S
NCT04518618
Comparison Between Bupivacaine With and Without Fentanyl in Reducing Pain During Cesarean Delivery Under Spinal Anaesthesia
NCT05491187
Quality of Postoperative Analgesia and Functional Recovery After Elective Cesarean Delivery
NCT06355271
Sequential Intrathecal Injection of Fentanyl and Hyperbaric Bupivacaine
NCT03415087
Analgesic Efficacy of Intrathecal Fentanyl-Morphine Combination Versus Morphine Alone for Intraoperative Pain During Elective Cesarean Delivery
NCT06570343
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
H-Bupivacaine 11.5 mg + fentanyl 25 mcg.
Intrathecal administration of Hyperbaric Bupivacaine 1.5 ml 0.75% plus fentanyl 25 mcg.
H-Bupivacaine
Intrathecal administration of hyperbaric bupivacaine 1.5 ml 0.75%
Fentanyl
Intrathecal administration of fentanyl 25 mcg
H-Bupivacaine 11.5 mg.
Intrathecal administration of Hyperbaric Bupivacaine 1.5 ml 0.75%
H-Bupivacaine
Intrathecal administration of hyperbaric bupivacaine 1.5 ml 0.75%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
H-Bupivacaine
Intrathecal administration of hyperbaric bupivacaine 1.5 ml 0.75%
Fentanyl
Intrathecal administration of fentanyl 25 mcg
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists classificationI or II.
* Between 18 and 40 years.
* Scheduled for elective cesarean section under spinal anesthesia in the Maternity Service of the Clinical Hospital of the Catholic University.
Exclusion Criteria
* Obesity\> 30 kg / m 2 before pregnancy.
* Background Of psychiatric illness.
* Using Chronic analgesic.
* AllergyDrug used in protocol.
* require General anesthesia during surgery
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pontificia Universidad Catolica de Chile
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Luis I Cortinez, MD
Role: STUDY_CHAIR
Ponticia Universidad Católica
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Clinico Pontificia Universidad Catolica
Santiago, Santiago Metropolitan, Chile
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-389
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.